Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Regulation of opioid receptors by cocaine.

Unterwald EM.

Ann N Y Acad Sci. 2001 Jun;937:74-92. Review.

PMID:
11458541
2.

Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems.

Shippenberg TS, Chefer VI, Zapata A, Heidbreder CA.

Ann N Y Acad Sci. 2001 Jun;937:50-73. Review.

PMID:
11458540
3.

Cocaine, dopamine and the endogenous opioid system.

Kreek MJ.

J Addict Dis. 1996;15(4):73-96. Review.

PMID:
8943583
4.

Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement.

Anderson SM, Pierce RC.

Pharmacol Ther. 2005 Jun;106(3):389-403. Epub 2005 Feb 26. Review.

PMID:
15922019
5.

Cortical mechanisms of cocaine sensitization.

Steketee JD.

Crit Rev Neurobiol. 2005;17(2):69-86. Review.

PMID:
16808728
6.

D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.

Hummel M, Unterwald EM.

J Cell Physiol. 2002 Apr;191(1):17-27. Review.

PMID:
11920678
7.

Rapid regulation of the dopamine transporter: role in stimulant addiction?

Zahniser NR, Sorkin A.

Neuropharmacology. 2004;47 Suppl 1:80-91. Review.

PMID:
15464127
8.

Genetic determinants of addiction to opioids and cocaine.

Saxon AJ, Oreskovich MR, Brkanac Z.

Harv Rev Psychiatry. 2005 Jul-Aug;13(4):218-32. Review.

PMID:
16126608
9.

Adaptations in adenosine signaling in drug dependence: therapeutic implications.

Hack SP, Christie MJ.

Crit Rev Neurobiol. 2003;15(3-4):235-74. Review.

PMID:
15248812
10.

Glutamate: the new frontier in pharmacotherapy for cocaine addiction.

Uys JD, LaLumiere RT.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):482-91. Review.

PMID:
19128205
11.

Opioids in chronic pain.

Przewłocki R, Przewłocka B.

Eur J Pharmacol. 2001 Oct 19;429(1-3):79-91. Review.

PMID:
11698029
12.

Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.

Bubar MJ, Cunningham KA.

Prog Brain Res. 2008;172:319-46. doi: 10.1016/S0079-6123(08)00916-3. Review.

PMID:
18772040
13.

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.

Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA.

Pharmacol Rev. 2005 Mar;57(1):1-26. Review.

14.

Endocrinological basis of sex differences in cocaine-induced behavioral responses.

Quiñones-Jenab V, Perrotti LI, Fabian SJ, Chin J, Russo SJ, Jenab S.

Ann N Y Acad Sci. 2001 Jun;937:140-71. Review.

PMID:
11458535
15.

The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Lutfy K, Zaveri NT.

Prog Mol Biol Transl Sci. 2016;137:149-81. doi: 10.1016/bs.pmbts.2015.10.003. Epub 2015 Dec 23. Review.

16.

Dopamine mechanisms and cocaine reward.

Ikegami A, Duvauchelle CL.

Int Rev Neurobiol. 2004;62:45-94. Review. No abstract available.

PMID:
15530568
17.

Opioid involvement in the rewarding effects of chronic cocaine.

Hammer RP Jr, Clow DW, Spear LP.

NIDA Res Monogr. 1990;105:182-8. Review. No abstract available.

PMID:
1652069
18.

Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER.

J Clin Invest. 2012 Oct;122(10):3387-93. doi: 10.1172/JCI60390. Epub 2012 Oct 1. Review.

19.

The role of serotonin in the actions of psychostimulants: molecular and pharmacological analyses.

Cunningham KA, Bradberry CW, Chang AS, Reith ME.

Behav Brain Res. 1996;73(1-2):93-102. Review.

PMID:
8788484
20.

The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Yoo JH, Kitchen I, Bailey A.

Br J Pharmacol. 2012 Aug;166(7):1993-2014. doi: 10.1111/j.1476-5381.2012.01952.x. Review.

Supplemental Content

Support Center